Recent news

Archived news

We have been informed by Israeli Patent Office that our patent application no 248011, concerning our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes is being processed. We are awaiting for further decisions.




Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes has been granted with Japanese patent no P6692796.

Patent no.6692796
.pdf
Download PDF • 1.46MB

.

We have been informed by Indian Patent Office that our patent application no 201647039411, concerning our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes is being processed. We are awaiting for further decisions.